Literature DB >> 23884856

Quality by design: scale-up of freeze-drying cycles in pharmaceutical industry.

Roberto Pisano1, Davide Fissore, Antonello A Barresi, Massimo Rastelli.   

Abstract

This paper shows the application of mathematical modeling to scale-up a cycle developed with lab-scale equipment on two different production units. The above method is based on a simplified model of the process parameterized with experimentally determined heat and mass transfer coefficients. In this study, the overall heat transfer coefficient between product and shelf was determined by using the gravimetric procedure, while the dried product resistance to vapor flow was determined through the pressure rise test technique. Once model parameters were determined, the freeze-drying cycle of a parenteral product was developed via dynamic design space for a lab-scale unit. Then, mathematical modeling was used to scale-up the above cycle in the production equipment. In this way, appropriate values were determined for processing conditions, which allow the replication, in the industrial unit, of the product dynamics observed in the small scale freeze-dryer. This study also showed how inter-vial variability, as well as model parameter uncertainty, can be taken into account during scale-up calculations.

Mesh:

Year:  2013        PMID: 23884856      PMCID: PMC3755168          DOI: 10.1208/s12249-013-0003-9

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  21 in total

1.  Freeze-drying process design by manometric temperature measurement: design of a smart freeze-dryer.

Authors:  Xiaolin Charlie Tang; Steven L Nail; Michael J Pikal
Journal:  Pharm Res       Date:  2005-04       Impact factor: 4.200

2.  Correlation of laboratory and production freeze drying cycles.

Authors:  Wei Y Kuu; Lisa M Hardwick; Michael J Akers
Journal:  Int J Pharm       Date:  2005-09-30       Impact factor: 5.875

3.  Heat and mass transfer scale-up issues during freeze-drying, III: control and characterization of dryer differences via operational qualification tests.

Authors:  S Rambhatla; S Tchessalov; Michael J Pikal
Journal:  AAPS PharmSciTech       Date:  2006-04-21       Impact factor: 3.246

4.  Evaluation of tunable diode laser absorption spectroscopy for in-process water vapor mass flux measurements during freeze drying.

Authors:  Henning Gieseler; William J Kessler; Michael Finson; Steven J Davis; Phillip A Mulhall; Vincent Bons; David J Debo; Michael J Pikal
Journal:  J Pharm Sci       Date:  2007-07       Impact factor: 3.534

5.  Lyophilization cycle development for a high-concentration monoclonal antibody formulation lacking a crystalline bulking agent.

Authors:  James D Colandene; Linda M Maldonado; Alma T Creagh; John S Vrettos; Kenneth G Goad; Thomas M Spitznagel
Journal:  J Pharm Sci       Date:  2007-06       Impact factor: 3.534

6.  Evaluation of manometric temperature measurement as a method of monitoring product temperature during lyophilization.

Authors:  N Milton; M J Pikal; M L Roy; S L Nail
Journal:  PDA J Pharm Sci Technol       Date:  1997 Jan-Feb

7.  Quality by design: optimization of a freeze-drying cycle via design space in case of heterogeneous drying behavior and influence of the freezing protocol.

Authors:  Roberto Pisano; Davide Fissore; Antonello A Barresi; Philippe Brayard; Pierre Chouvenc; Bertrand Woinet
Journal:  Pharm Dev Technol       Date:  2012-10-19       Impact factor: 3.133

8.  Development of an efficient single-step freeze-drying cycle for protein formulations.

Authors:  B S Chang; N L Fischer
Journal:  Pharm Res       Date:  1995-06       Impact factor: 4.200

9.  Heat and mass transfer scale-up issues during freeze drying: II. Control and characterization of the degree of supercooling.

Authors:  Shailaja Rambhatla; Roee Ramot; Chandan Bhugra; Michael J Pikal
Journal:  AAPS PharmSciTech       Date:  2004-08-05       Impact factor: 3.246

10.  Heat and mass transfer scale-up issues during freeze-drying, I: atypical radiation and the edge vial effect.

Authors:  Shailaja Rambhatla; Michael J Pikal
Journal:  AAPS PharmSciTech       Date:  2003       Impact factor: 3.246

View more
  7 in total

1.  Finite Element Method (FEM) Modeling of Freeze-drying: Monitoring Pharmaceutical Product Robustness During Lyophilization.

Authors:  Xiaodong Chen; Vikram Sadineni; Mita Maity; Yong Quan; Matthew Enterline; Rao V Mantri
Journal:  AAPS PharmSciTech       Date:  2015-03-20       Impact factor: 3.246

Review 2.  Freeze-drying for the preservation of immunoengineering products.

Authors:  Nagavendra Kommineni; Arun Butreddy; Vaskuri G S Sainaga Jyothi; Pavimol Angsantikul
Journal:  iScience       Date:  2022-09-13

Review 3.  Pharmaceutical protein solids: Drying technology, solid-state characterization and stability.

Authors:  Yuan Chen; Tarun Tejasvi Mutukuri; Nathan E Wilson; Qi Tony Zhou
Journal:  Adv Drug Deliv Rev       Date:  2021-03-08       Impact factor: 15.470

4.  The Production of a Stable Infliximab Powder: The Evaluation of Spray and Freeze-Drying for Production.

Authors:  Gaurav Kanojia; Rimko Ten Have; Arjen Bakker; Koen Wagner; Henderik W Frijlink; Gideon F A Kersten; Jean-Pierre Amorij
Journal:  PLoS One       Date:  2016-10-05       Impact factor: 3.240

5.  Demonstrating Functional Equivalence of Pilot and Production Scale Freeze-Drying of BCG.

Authors:  R Ten Have; K Reubsaet; P van Herpen; G Kersten; J-P Amorij
Journal:  PLoS One       Date:  2016-03-16       Impact factor: 3.240

6.  Molded Vial Manufacturing and Its Impact on Heat Transfer during Freeze-Drying: Vial Geometry Considerations.

Authors:  Tim Wenzel; Henning Gieseler
Journal:  AAPS PharmSciTech       Date:  2021-01-27       Impact factor: 3.246

7.  Lyophilization and homogenization of biological samples improves reproducibility and reduces standard deviation in molecular biology techniques.

Authors:  Agnes Molnar; Tamas Lakat; Adam Hosszu; Beata Szebeni; Anna Balogh; Laszlo Orfi; Attila J Szabo; Andrea Fekete; Judit Hodrea
Journal:  Amino Acids       Date:  2021-05-17       Impact factor: 3.520

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.